Edurne Rujas

Edurne Rujas is an Ikerbasque Research Fellow at the University of the Basque Country (UPV/EHU), affiliated with the Biofisika Institute (CSIC, EHU). She leads the Antibody Engineering Group under the Fundación Biofísica Bizkaia, focusing on the development of novel antibody-based biotherapeutics for cancer and infectious diseases.

Her research lies at the intersection of immunobiophysics and protein engineering, with a strong emphasis on enhancing antibody potency through multivalency, multispecificity, and membrane interface interactions. Her work has significant implications for HIV-1 and SARS-CoV-2 therapeutics and vaccine design.

The trends in her recent publications reveal a consistent focus on engineering high-avidity, multimeric antibody platforms that achieve ultrapotent neutralization of viruses such as HIV-1 and SARS-CoV-2. Her studies frequently combine structural insights with functional assays to elucidate mechanisms of antibody-membrane interactions and viral entry inhibition.

• Ikerbasque Research Fellow
• Marie-Sklodowska Curie Postdoctoral Fellow

Dr. Rujas has contributed to over 8 intellectual property disclosures and has co-founded the biotech company Radiant Biotherapeutics based on her platform for multimeric antibody display. Her research has been supported by prestigious fellowships and collaborative grants, though specific funding sources are not detailed in the provided text.

She conducts her research at the Immunobiophysics and Antibody Engineering Laboratory within the Biofisika Institute, a prominent interdisciplinary research center in biophysics and molecular life sciences.